Published in J Am Coll Cardiol on April 01, 1996
Validity of the surface electrocardiogram criteria for right ventricular hypertrophy: the MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle). J Am Coll Cardiol (2013) 2.05
Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart (1998) 1.68
N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. Eur Heart J (2012) 1.55
Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study. Circulation (2008) 1.09
ST-T segment changes in patients with tricyclic antidepressant poisoning. J Res Pharm Pract (2013) 0.82
Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms. Am Heart J (2009) 0.80
The ischemic electrocardiogram: a harbinger for ischemic heart disease independent of the blood pressure level. The Copenhagen City Heart Study. Eur J Epidemiol (2005) 0.78
Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation study. BMC Cardiovasc Disord (2007) 0.78
Electrocardiographic precordial ST-segment deviations and the risk of cardiovascular death: results from the Copenhagen ECG Study. J Am Heart Assoc (2014) 0.77
Arterial stiffness and pulse wave reflection are increased in patients suffering from severe periodontitis. PLoS One (2014) 0.77
Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study. J Am Soc Hypertens (2016) 0.75
[Standard-ECG]. Herzschrittmacherther Elektrophysiol (2008) 0.75
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care (1997) 7.85
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J (2002) 2.60
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ (1992) 2.39
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med (1995) 2.14
Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Heart J (1998) 1.99
Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ (1991) 1.86
Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev (1997) 1.80
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Low iron-binding capacity as a risk factor for myocardial infarction. Circulation (1994) 1.68
Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab (1998) 1.60
Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. Eur Heart J (1987) 1.45
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1998) 1.42
Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand (1995) 1.38
Epidemiology of breast cancer in families in Iceland. J Med Genet (1992) 1.36
The vascular endothelium-pathobiologic significance. Am J Pathol (1978) 1.30
Effects of leisure-time physical activity and ventilatory function on risk for stroke in men: the Reykjavík Study. Ann Intern Med (1999) 1.27
The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet (2002) 1.26
Resuscitation in Europe: a tale of five European regions. Resuscitation (1999) 1.20
Migration of human vascular endothelial and smooth muscle cells. Lab Invest (1979) 1.16
Familial breast cancer in Iceland. Int J Cancer (1982) 1.13
Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-1991--the Reykjavik Study. Diabet Med (1997) 1.13
Neoplastic diseases in families of breast cancer patients. J Med Genet (1994) 1.11
Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. Eur Heart J (1993) 1.10
Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik Study. Cephalalgia (2006) 1.09
Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl (1993) 1.07
Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study. Int J Epidemiol (1995) 1.05
Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up. J Intern Med (1998) 1.02
Familial non-medullary thyroid cancer in Iceland. J Med Genet (2001) 1.02
Platelet factors and the human vascular wall. Part 2. Such factors are not required for endothelial cell proliferation and migration. Atherosclerosis (1978) 1.01
Tumours in Iceland. 10. Malignant tumours of the female breast. A histological classification, laterality, survival and epidemiological considerations. APMIS (1988) 1.00
The relationship between educational level and mortality. The Reykjavík Study. J Intern Med (2001) 0.98
Gastric cancer after gastrectomy. Int J Cancer (1988) 0.98
Community screening for glucose intolerance in middle-aged Icelandic men. Deterioration to diabetes over a period of 71/2 years. Acta Med Scand (1981) 0.98
Reproductive factors and breast cancer risk in Iceland. A second cohort study. Int J Cancer (1990) 0.97
C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia (2009) 0.96
The epidemiology of right bundle branch block and its association with cardiovascular morbidity--the Reykjavik Study. Eur Heart J (1993) 0.95
Prostate cancer--look to Denmark? J Natl Cancer Inst (1996) 0.93
Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev (2002) 0.92
Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours. Acta Oncol (1989) 0.92
Predominance of aortic calcification as an atherosclerotic manifestation in women: the Reykjavik study. J Clin Epidemiol (1996) 0.90
Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995. J Med Genet (1999) 0.90
Role of phosphoinositides in the regulation of endothelial prostacyclin production. Arteriosclerosis (1988) 0.89
The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old Icelandic women. Osteoporos Int (2000) 0.89
A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol--the Reykjavik Study. J Clin Epidemiol (1994) 0.88
Serum thyroglobulin as a risk factor for thyroid carcinoma. Acta Oncol (2000) 0.88
Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol (1992) 0.88
Left and right sided breast cancer. Pathol Res Pract (1990) 0.88
Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol (2007) 0.87
Endothelial inositol phosphate generation and prostacyclin production in response to G-protein activation by AlF4-. Biochem J (1989) 0.87
The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study. J Intern Med (1999) 0.87
Platelet factors and the human vascular wall: variations in growth response between endothelial and medial smooth muscle cells. Atherosclerosis (1978) 0.86
Increasing glucose levels and BMI predict future heart failure experience from the Reykjavík Study. Eur J Heart Fail (2007) 0.86
Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykjavik Study. J Hum Hypertens (2004) 0.86
Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees. Genet Epidemiol (2000) 0.86
Cholecystectomy and colorectal carcinoma: a total-population historical prospective study. Am J Gastroenterol (1991) 0.85
Desensitization of inositol phosphate production after agonist stimulation of endothelial cells is not mediated by protein kinase C. Biochem Biophys Res Commun (1989) 0.84
Risk factors and outcome in ICU-acquired infections. Acta Anaesthesiol Scand (2008) 0.83
Prognostic role of cardiovascular risk factors for men with cardiomegaly (the Reykjavik Study). Am J Cardiol (1996) 0.83
Natural history of chronic left ventricular aneurysm; a population based cohort study. J Clin Epidemiol (1991) 0.83
Involvement of MAP kinases in the control of cPLA(2) and arachidonic acid release in endothelial cells. Atherosclerosis (2001) 0.82
Comparison of interventional cardiology in two European countries: a nationwide Internet based registry study. Int J Cardiol (2012) 0.82
Total cholesterol and mortality after age 80 years. Lancet (1997) 0.80
Actinobacillus actinomycetemcomitans and endocarditis. J Infect Dis (1988) 0.80